| All participants (n = 505) | P value | Individuals with diabetes (n = 286) | p value | Individuals without diabetes (n = 219) | p value |
---|---|---|---|---|---|---|
All-cause death, n (%) | 178 (35.2) | Â | 129 (45.1) | Â | 49 (22.4) | Â |
 Crude HR (95% CI) | 1.69 (1.48–1.93) |  < 0.001 | 1.52 (1.30–1.76) |  < 0.001 | 1.82 (1.34–2.47) |  < 0.001 |
 Model 1 HR (95% CI) | 1.61 (1.41–1.83) |  < 0.001 | 1.46 (1.25–1.69) |  < 0.001 | 1.86 (1.34–4.51) |  < 0.001 |
 Model 2 HR (95% CI) | 1.47 (1.28–1.73) |  < 0.001 | 1.42 (1.21–1.67) |  < 0.001 | 1.67 (1.17–2.36) | 0.004 |
 Model 3 HR (95% CI) | 1.37 (1.12–1.68) | 0.002 | 1.47 (1.16–1.87) | 0.002 | 1.18 (0.73–1.92) | 0.50 |
CVD death, n (%) | 87 (17.2) | Â | 67 (23.4) | Â | 20 (9.1) | Â |
 Crude HR (95% CI) | 2.04 (1.69–2.45) |  < 0.001 | 1.73 (1.40–2.13) |  < 0.001 | 2.73 (1.74–4.28) |  < 0.001 |
 Model 1 HR (95% CI) | 1.91 (1.58–2.30) |  < 0.001 | 1.63 (1.32–2.01) |  < 0.001 | 2.82 (1.75–4.56) |  < 0.001 |
 Model 2 HR (95% CI) | 1.75 (1.43–2.14) |  < 0.001 | 1.58 (1.27–1.98) |  < 0.001 | 2.31 (1.39–3.83) | 0.001 |
 Model 3 HR (95% CI) | 1.50 (1.12–2.00) | 0.006 | 1.53 (1.10–2.14) | 0.012 | 1.31 (0.65–2.63) | 0.44 |
Non-CVD death, n (%) | 91 (18.0) | Â | 62 (21.7) | Â | 29 (13.2) | Â |
 Crude HR (95% CI) | 1.38 (1.13–1.68) | 0.001 | 1.30 (1.04–1.62) | 0.023 | 1.30 (0.83–2.01) | 0.25 |
 Model 1 HR (95% CI) | 1.33 (1.09–1.61) | 0.004 | 1.26 (1.01–1.58) | 0.04 | 1.29 (0.81–2.06) | 0.29 |
 Model 2 HR (95% CI) | 1.23 (1.00–1.51) | 0.046 | 1.24 (0.98–1.57) | 0.069 | 1.22 (0.73–2.02) | 0.45 |
 Model 3 HR (95% CI) | 1.24 (0.93–1.66) | 0.15 | 1.39 (0.98–1.96) | 0.062 | 1.01 (0.51–2.00) | 0.98 |